Hims & Hers Charts Ambitious Course with Dual Acquisitions

Hims & Hers US4330001060

Following a year of stock market volatility, telehealth provider Hims & Hers Health is aggressively pursuing its long-term 2030 vision. The company recently unveiled two strategic acquisitions designed to fuel expansion on both geographic and technological fronts, even as its share price undergoes a correction.

These strategic initiatives are built upon a foundation of robust operational performance. For the third quarter of 2025, the company reported a 49% surge in revenue, reaching nearly $600 million. Adjusted EBITDA also saw significant growth, climbing to over $78 million.